Company Filing History:
Years Active: 2023
Title: Suzanne A. Sprunger: Innovator in Proinsulin Polypeptides
Introduction
Suzanne A. Sprunger is a notable inventor based in Port Ludlow, WA (US). She has made significant contributions to the field of biotechnology, particularly in the development of proinsulin polypeptides. Her work has implications for diabetes treatment and insulin production.
Latest Patents
Suzanne holds a patent for "C-peptides and proinsulin polypeptides comprising the same." This invention features a connecting polypeptide with SEQ ID NO:73. The proinsulin polypeptide includes a mature insulin A-chain, a mature insulin B-chain, and a connecting peptide that links the two chains. Notably, the connecting peptide is not a native human proinsulin C-peptide. The proinsulin polypeptides developed through this invention can be produced in high titers and high purity, showcasing her innovative approach to biotechnology.
Career Highlights
Suzanne is currently associated with Absci LLC, where she continues to advance her research and development efforts. Her work at Absci LLC emphasizes the importance of innovation in the biotechnology sector, particularly in the production of therapeutic proteins.
Collaborations
Suzanne has collaborated with talented individuals such as Amy Doerner and Michael Cammarata. These partnerships highlight the collaborative nature of scientific research and the importance of teamwork in achieving groundbreaking results.
Conclusion
Suzanne A. Sprunger's contributions to the field of biotechnology, particularly through her patent on proinsulin polypeptides, demonstrate her commitment to innovation and improving healthcare solutions. Her work continues to inspire advancements in diabetes treatment and insulin production.